Wegovy contains the active ingredient semaglutide and is available in the following dose forms: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg
Lowers Blood Pressure Many patients experience a reduction in blood pressure while taking semaglutide which could lead to a decreased risk of cardiovascular disease and contributes to overall cardiovascular health
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
It is not just another diet pill or a quick fix
Outgoing chair Mr Lund said that the Novo Nordisk board had proposed bringing in several new board members to add new skills, but the Novo Nordisk Foundation "wanted a more extensive reconfiguration"
proposed that in the initiation of HF, myocardial fatty acid, glucose, ketone body, and branched-chain amino acid metabolism is disturbed, leading to alterations in myocardial structure and function 26,40